一名肝移植术后接受FK506免疫抑制治疗的儿童发生糖尿病酮症酸中毒。
Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant.
作者信息
Keshavarz Reza, Mousavi Mohammad-Ali, Hassani Cameron
机构信息
Department of Emergency Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
出版信息
Pediatr Emerg Care. 2002 Feb;18(1):22-4. doi: 10.1097/00006565-200202000-00007.
Abstract
The use of immunosuppressive agents is becoming more widespread, especially in the context of organ transplantation. We report a child with a complication, new-onset diabetes mellitus with diabetic ketoacidosis, associated with the use of one such agent, FK506 (tacrolimus).
摘要
免疫抑制剂的使用越来越普遍，尤其是在器官移植的背景下。我们报告了一名儿童出现了一种并发症，即新发糖尿病伴糖尿病酮症酸中毒，这与使用其中一种药物FK506（他克莫司）有关。
Zotero 插件